Recent developments in immunotherapy of acute myeloid leukemia

Abstract The advent of new immunotherapeutic agents in clinical practice has revolutionized cancer treatment in the past decade, both in oncology and hematology. The transfer of the immunotherapeutic concepts to the treatment of acute myeloid leukemia (AML) is hampered by various characteristics of...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Felix S. Lichtenegger, Christina Krupka, Sascha Haubner, Thomas Köhnke, Marion Subklewe
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2017-07-01
coleção:	Journal of Hematology & Oncology
Assuntos:	AML Antibody therapy Bispecific antibody CAR T cell Checkpoint inhibition Dendritic cell vaccination
Acesso em linha:	http://link.springer.com/article/10.1186/s13045-017-0505-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!